Independent fund research. Built on SEC filings.

How we research funds

BlackRock · Health Care Sector

Blackrock Health Sciences Opportunities Portfolio: share classes compared

Blackrock Health Sciences Opportunities Portfolio has 6 share classes (4 with public tickers). They hold the same portfolio — $5.9 billion in total — but charge different fees and loads. The cheapest is SHSSX (Institutional) at 0.86%.

TickerShare classTypeExpense ratioFront load12b-11-yr5-yr10-yr
SHSSXInstitutionalMutual fund 0.86%0%0% +16.3%+5.9%+9.8%
SHSAXInvestor AMutual fund 1.11%5.25%0.25% +9.9%+4.5%+9.0%
SHSCXInvestor CMutual fund 1.9%0%1% +14.1%+4.8%+8.9%
SHISXServiceMutual fund 1.16%—0.25% +15.9%+5.5%+9.5%
—Class R SharesMutual fund 1.47%0%0.5% +15.6%+5.2%+9.2%
—Class KMutual fund 0.76%—0% +16.4%+5.9%+9.9%

Source: Fund prospectus, filed Sep 25, 2026

Objective

The investment objective of BlackRock Health Sciences Opportunities Portfolio (the Fund), a series of BlackRock Funds SM (the Trust), is to provide long-term growth of capital.

Top holdings

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%